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A B S T R A C T
Objectives: Fetal exposure to phthalates and bisphenols may lead to vascular developmental adaptations, which
program later cardiovascular disease. We examined the associations of fetal exposure to phthalates and bi-
sphenols with childhood blood pressure.
Methods: In a population-based, prospective cohort study among 1,064 mother-child pairs, we measured ma-
ternal urine phthalate and bisphenol concentrations in first, second and third trimester of pregnancy. We
measured childhood blood pressure at the mean age of 9.7 years (standard deviation 0.2 years) old. Analyses
were performed for the total group, and for boys and girls separately.
Results: Maternal urine phthalate concentrations were not associated with childhood blood pressure among
boys. Higher third trimester maternal urine concentrations of high molecular weight phthalates (HMWP), di-2-
ehtylhexylphthalate (DEHP) and di-n-octylphthalate (DNOP) were associated with lower systolic and diastolic
blood pressure among girls (p-values < 0.01). Also, higher second trimester maternal urine total bisphenol and
bisphenol A concentrations were associated with higher systolic blood pressure among boys (p values < 0.01),
but tended to be associated with a lower diastolic blood pressure among girls.
Conclusions: Our results suggest sex-dependent associations of maternal urine phthalate and bisphenol con-
centrations during pregnancy with childhood blood pressure. Further studies are needed to explore the under-
lying mechanisms and long term consequences.
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1. Introduction
Pregnant women are exposed to a variety of endocrine-disrupting
chemicals, such as phthalates and bisphenols. (Ye et al., 2008) Phtha-
lates and bisphenols are widely used, including in food packaging,
household products and medical devices. (Russo et al., 2019; Schettler,
2006) They are able to pass the placenta and may thereby cause car-
diovascular developmental adaptations, which in turn may influence
the risk of cardiovascular disease later in life. (Nahar et al., 2015; Mose
et al., 2007) It has been hypothesized that exposure to phthalates and
bisphenols during fetal life is associated with an increased cardiovas-
cular risk later in life. (Chapalamadugu et al., 2014) The mechanisms
by which phthalates and bisphenols affect early-life vascular develop-
ment may include their influence on estrogen and androgen receptors,
thyroid metabolism, the activation of peroxisome proliferator-activated
receptors (PPARs) or retinoid X receptors (RXRs), affecting the fetal
transcriptome and DNA methylation. (Mattison et al., 2014; Shen et al.,
2009; Dolinoy et al., 2007; Solomon et al., 2017; Mou et al., 2018) Due
to their influence on estrogen and androgen receptors, the effects of
phthalates and bisphenols on cardiovascular health might differ for
boys and girls.
The associations of phthalates and bisphenol A (BPA) with cardio-
vascular risk factors, such as obesity, hypertension and diabetes, have
mainly been studied in cross-sectional designs among adult populations
and showed inconsistent results. (Ranciere et al., 2015; Trasande et al.,
2013; Zhang et al., 2018; Buser et al., 2014; Golestanzadeh et al., 2019)
Previous prospective studies on the associations of fetal exposure to
phthalates or bisphenols with childhood blood pressure are scarce and
also showed inconsistent results. (Vafeiadi et al., 2016; Bae et al., 2017;
Vafeiadi et al., 2018; Valvi et al., 2015; Warembourg et al., 2019) Some
studies did not show any association of fetal exposure to BPA with
childhood blood pressure, while others showed that fetal exposure to
BPA was associated with higher diastolic blood pressure. (Vafeiadi
et al., 2016; Bae et al., 2017; Warembourg et al., 2019) Studies in-
vestigating the associations of fetal phthalate exposure with childhood
blood pressure reported sex specific effects. (Vafeiadi et al., 2018; Valvi
et al., 2015) The samples from previous studies were small with 230 to
480 mother–child pairs, with follow up until the age of 7 years. A recent
study reported associations of prenatal maternal BPA urine concentra-
tions with childhood blood pressure at 6.5–11 years old in 1,277 chil-
dren form multiple European birth cohorts. (Warembourg et al., 2019)
These studies mostly used only one measure of phthalate or bisphenol
exposure.
We hypothesized that fetal exposure to higher levels of maternal
phthalate and bisphenol concentrations lead to developmental vascular
adaptations and subsequent higher blood pressure during childhood.
We assessed, in a population-based cohort study from fetal life onwards
among 1,064 mother–child pairs, the sex-specific associations of ma-
ternal phthalate and bisphenol urine concentrations in first, second and
third trimester of pregnancy with childhood blood pressure.
2. Materials and methods
2.1. Study design
This study was embedded in the Generation R Study, a population-
based prospective cohort study from early fetal life onwards in
Rotterdam, the Netherlands. (Jaddoe et al., 2012) Phthalate and bi-
sphenol concentrations in urine were measured among a subgroup of
1,405 mothers, whose singleton children also participated in postnatal
studies. We excluded mothers without information on phthalate and
bisphenol urine concentrations for at least one time point in pregnancy
and whose children had no measurement of blood pressure at 10 years.
The population for analysis comprised 1,064 mother–child pairs (Sup-
plemental Figure 1). The study has been approved by the Medical
Ethical Committee of the Erasmus MC, University Medical Centre in
Rotterdam. Written informed consent was obtained from all partici-
pants.
2.2. Maternal phthalate and bisphenol urine concentrations
Phthalate and bisphenol concentrations were measured in spot
urine samples obtained from each woman at three time points during
pregnancy (median 12.9 weeks of gestation (25th-75th percentiles 12.1
– 14.5); median 20.4 weeks of gestation (25th-75th percentiles 19.9 –
20.9); median 30.2 weeks of gestation (25th-75th percentiles 29.9 –
30.8)). These periods were considered as first, second and third tri-
mester. Urine samples were collected between February 2004 and July
2005. The analyses of phthalate, bisphenol and creatinine concentra-
tions were performed at the Wadsworth Center, New York State
Department of Health, Albany, New York, USA, using previously de-
scribed methods. (Philips et al., 2018) Urine biomarkers for exposure to
phthalate metabolites were grouped according to their molecular
weight and parent phthalates into low molecular weight phthalate
(LMWP) and high molecular weight phthalate (HMWP), which includes
subgroups of di-2-ethylhexylphthalate (DEHP) and di-n-octylphthalate
(DNOP) metabolites. Phthalic acid (PA) was analyzed separately as a
proxy for total phthalate exposure. Individual phthalates were analyzed
as a sensitivity analysis. Bisphenols A (BPA), S (BPS) and F (BPF) were
grouped and used as proxy for total bisphenol exposure. Further details
on how we grouped the individual phthalates and bisphenols are pro-
vided in Supplemental Methods. Weighted molar sums were calculated
for the different groups of phthalates and bisphenols. Individual
phthalates and bisphenols were included in the groups if < 80% of
their concentrations at that time point was below the limit of detection
(LOD). All concentrations below the LOD were substituted by LOD di-
vided by the square root of 2 (LOD/√2). (Hornung, 1990) The de-
scriptive statistics of the individual and grouped phthalates and bi-
sphenols investigated are shown for boys and girls in Table 1
(Supplemental Table 1 shows this information for the total group and
the limit of detection). The intraclass correlation coefficients between
natural log-transformed phthalate and bisphenol urine concentrations
across pregnancy were assessed using a single measurement, absolute
agreement and two-way mixed effects model and varied between 0.06
and 0.36 (Supplemental Table 1). To account for urine dilution, urine
phthalate and bisphenol concentrations were converted to µmol/g
creatinine for the metabolite groups. To reduce the potential for ex-
posure misclassification due to temporal variability, we calculated the
overall mean exposure during pregnancy by summing the first, second
and third trimester phthalate and bisphenol concentrations and di-
viding by the three time points.
2.3. Childhood blood pressure
As described previously, children were invited to visit our research
center around the age of 10 years. (Kooijman et al., 2016) We measured
systolic and diastolic blood pressure at the right brachial artery four
times with one minute intervals, using the validated automatic sphyg-
momanometer Datascope Accutor Plus (Paramus, NJ, USA) with an
appropriate cuff. We calculated the mean value for systolic and diastolic
blood pressure using the last three measurements of each participant.
(Wong et al., 2006)
2.4. Covariates
Information on maternal characteristics, including age, ethnicity,
pre-pregnancy body mass index, use of folic acid supplementation,
educational level, parity, and maternal smoking habits and alcohol
consumption (specifically in first, second and third trimester of preg-
nancy or during pregnancy) were obtained from questionnaires during
pregnancy. Child’s sex was obtained from midwife and hospital records
at birth. A Directed Acyclic Graph (DAG) showing the hypothesized
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3
relationships between fetal exposure to phthalates and bisphenols,
childhood blood pressure and the covariates is presented in
Supplemental Figure 2.
2.5. Statistical analysis
For all analyses, urine phthalate and bisphenol concentrations were
natural log-transformed to reduce variability and account for right
skewedness of the distribution and further standardized by the inter-
quartile range (IQR) to ease the interpretation of effect sizes. We con-
structed standard deviation scores (SDS) [(observed value - mean)/
standard deviation (SD)] of the blood pressure based on the sample
distribution to enable comparisons of effect sizes. To assess possible
bias due to loss-to-follow-up, participants were compared to non-par-
ticipants using a Chi-squared test, student’s t-test or Mann-Whitney U
test, when applicable. We used linear regression models to assess the
associations of maternal urine phthalate and bisphenol concentrations
(per time point and overall mean during pregnancy) with childhood
blood pressure. Non-linearity of the relationship was visually assessed
and ruled out. First, models were adjusted for child’s sex- and age-ad-
justed height SDS, age and sex only (basic model). Subsequently, po-
tential confounders were identified based on the graphical criteria for
confounding by visualizing a DAG. Of these potential confounders, we
included those in the models that changed the effect estimates > 10%
for at least one of the outcomes. (Santos et al., 2019) To examine the
independent associations of maternal first, second and third trimester
phthalate and bisphenol concentrations with childhood blood pressure,
we created a mutually adjusted model by simultaneously including the
exposures at all three time points during pregnancy in the model. Based
on our hypothesis of sex-specific effects, we tested for statistical inter-
action of child’s sex. Since we observed significant interactions for
child’s sex, all results were presented for boys and girls separately
(Table 3 and Table 4). Previous studies have suggested that the effect of
exposure to phthalates and bisphenols on blood pressure could be
through DNA methylation changes. (Dolinoy et al., 2007; Solomon
et al., 2017; Mou et al., 2018) Because folic acid can influence me-
thylation, the use of folic acid supplementation might modify the as-
sociations of phthalates and bisphenols with blood pressure. (Dolinoy
et al., 2007; Pauwels et al., 2017) Since we did not observe statistically
significant interactions of the interaction (p-values > 0.10), no further
stratified analyses were performed. To exclude potential effects of
prematurity or low birth weight, we performed a sensitivity analysis
excluding children born preterm (meaning being born before 37 weeks
of gestation) or with low birth weight (meaning being born below or at
the 10th percentile for birth weight as based on gestational age-ad-
justed SDS for birth weight using North European growth standards as
the reference growth curve). (Niklasson et al., 1991) To correct for
multiple hypothesis testing, each p-value was compared with a
threshold defined as 0.05 divided by the effective number of in-
dependent tests estimated based on the correlation structure between
the exposures (p-value threshold of 0.0098). (Li et al., 2012) To
maintain statistical power and reduce bias related to missing data on
covariates, we performed multiple imputation of the covariates ac-
cording to the Markov Chain Monte Carlo method. The percentage of
missing values for covariates ranged from 0 to 20%. Covariates were
used as predictor variables and imputed when necessary, blood pressure
was used as predictor variable only. Ten imputed datasets were created
and no substantial differences were found between the original and
imputed datasets. We present results based on pooled imputed datasets.
All statistical analyses were performed using the Statistical Package of
Social Sciences version 25.0 for Windows (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Participant characteristics
Table 2 shows the characteristics for the total group and for boys
and girls separately. Non-response analyses showed that non-partici-
pating mothers tended to have higher urine phthalate concentrations,
were younger, lower educated, more often multiparous, of non-Eur-
opean descent and less likely to take folic acid supplementation or
consume alcohol during pregnancy (Supplemental Tables S2 and S3).
3.2. Maternal urine phthalate concentrations and childhood blood pressure
Table 3 shows that among boys, maternal urine phthalate con-
centrations were not associated with childhood systolic or diastolic
blood pressure after adjustment for confounders. Among girls, an IQR
increase in the natural log-transformed maternal third trimester urine
HMWP, DEHP and DNOP concentrations were associated with a 0.14
(95% confidence interval (95% CI) 0.24; 0.05), 0.13 (95% CI 0.22;
0.03) and 0.11 (95% CI 0.21; 0.01) SDS lower systolic blood pressure,
and a 0.21 (95% CI 0.30; 0.11), 0.18 (95% CI 0.28; 0.09) and 0.17 (95%
CI 0.26; 0.07) SDS lower diastolic blood pressure, respectively (Table 3,
basic models given in Supplemental Table S4). Of these associations,
only the associations of maternal third trimester urine DNOP con-
centrations with systolic blood pressure did not remain significant after
correction for multiple testing. In the mutually adjusted model, these
associations among girls remained significant (Supplemental Table S5).
However, the associations of maternal third trimester urine DEHP and
DNOP concentrations with offspring systolic blood pressure in the
mutually adjusted model did not remain significant after correction for
Table 2
Characteristics of mothers and their children.
Total group Boys Girls
n = 1,064 n = 538
(50.6%)
n = 526
(49.4)
Maternal characteristics
Age at enrolment, mean (SD)
(years)
30.9 (4.6) 30.9 (4.6) 30.8 (4.6)
Parity, n (%)
Nullipara 666 (62.9%) 338 (63.1%) 328 (62.8%)
Multipara 392 (37.1%) 198 (36.9%) 194 (37.2%)
Ethnicity, n (%)
European 692 (65.4%) 356 (66.5%) 336 (64.2%)
Non-European 366 (34.6%) 179 (33.5%) 187 (35.8%)
Education, n (%)
Low 67 (6.5%) 32 (6.2%) 35 (6.9%)
Middle 470 (39.5%) 199 (38.3%) 208 (40.6%)
High 556 (54.0%) 289 (55.6%) 276 (52.4%)
Pre-pregnancy BMI, median
(95% range) (kg/m2)
22.7 (18.5 –
34.9)
22.7 (18.6 –
35.0)
22.7 (18.4 –
35.0)
Folic acid supplementation, n
(%), yes
708 (83.2%) 364 (83.7%) 344 (82.7%)
Smoking during pregnancy, n
(%), yes
222 (22.9%) 110 (22.9%) 112 (22.9%)
First trimester, n (%), yes 189 (20.0%) 94 (20.0%) 95 (19.9%)
Second trimester, n (%), yes 96 (10.3%) 47 (9.8%) 49 (10.8%)
Third trimester, n (%), yes 97 (10.5%) 54 (11.3%) 43 (9.6%)
Alcohol consumption during
pregnancy (any), n (%), yes
581 (60.4%) 305 (63.5%) 276 (57.3%)
First trimester, n (%), yes 492 (52.1%) 263 (55.7%) 229 (48.4%)
Second trimester, n (%), yes 342 (36.7%) 184 (38.8%) 158 (34.5%)
Third trimester, n (%), yes 361 (39.1%) 199 (42.0%) 162 (30.8%)
Child characteristics
Age, mean (SD) (years) 9.7 (0.2) 9.7 (0.3) 9.7 (0.2)
BMI, median (95% range) (kg/
m2)
16.8 (14.0 –
24.9)
17.3 (14.0 –
24.5)
16.9 (14.0 –
25.2)
Average diastolic blood pressure,
mean (SD) (mmHg)a
58.6 (6.7) 57.9 (6.8) 59.3 (6.6)
Average systolic blood pressure,
mean (SD) (mmHg)a
103.0 (8.2) 102.5 (7.9) 103.6 (8.4)
Values represent mean (SD), median (95% range) or number of subjects (valid
%).
a The average of the last 3 of 4 measurements was used.
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multiple testing. The associations of second trimester maternal urine
LMWP concentrations with systolic blood pressure and third trimester
maternal urine PA and LMWP concentrations with diastolic blood
pressure in girls did not remain significant after adjustment for con-
founders and correction for multiple testing (Table 3, basic models
given in Supplemental Table S4). Higher overall means of maternal
urine HMWP, DEHP and DNOP concentrations were also associated
with a lower blood pressure among girls, but only the associations of an
IQR increase in the natural log transformed overall mean maternal
urine HMWP, DEHP and DNOP concentrations with a 0.17 (95% CI
0.26; 0.07), 0.15 (95% CI 0.25; 0.06) and 0.15 (95% CI 0.24; 0.05) SDS
lower diastolic blood pressure remained significant after correction for
multiple testing (Supplemental Table S6). When examining associations
of maternal urine concentrations of individual phthalates with child-
hood blood pressure, there were multiple associations of higher third
trimester maternal urine concentrations of high-molecular weight
phthalates such as monobenzylphthalate (mBzBP), mono-(2-ethyl-5-
carboxypentyl)phthalate (mECPP), mono-(2-ethyl-5-hydroxyhexyl)
phthalate (mEHPP), mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP),
mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP) and mono(3-
Table 3
Associations of maternal phthalate urine concentration during pregnancy with childhood blood pressure at 10 years, stratified for boys and girls.
Measures of blood pressure at 10 years (in standard deviation scores, 95% confidence interval)
Mean systolic blood pressure Mean diastolic blood pressure
Exposure Trimester Boys Girls p-value$ Boys Girls p-value$
PA First trimester 0.04 (−0.05; 0.14) −0.03 (−0.13; 0.07) 0.322 0.01 (−0.09; 0.11) −0.03 (−0.13; 0.07) 0.311
Second trimester 0.07 (−0.04; 0.18) 0.02 (−0.10; 0.14) 0.626 0.02 (−0.10; 0.14) 0.01 (−0.11; 0.14) 0.777
Third trimester 0.03 (−0.07; 0.13) −0.03 (−0.15; 0.08) 0.412 −0.05 (−0.16; 0.06) −0.12 (−0.24; −0.01)* 0.254
LMWP First trimester 0.04 (−0.07; 0.14) 0.04 (−0.08; 0.15) 0.973 0.04 (−0.07; 0.16) 0.01 (−0.11; 0.12) 0.363
Second trimester 0.05 (−0.06; 0.16) 0.11 (−0.01; 0.23) 0.457 −0.06 (−0.18; 0.06) 0.09 (−0.03; 0.21) 0.203
Third trimester −0.00 (−0.12; 0.11) −0.03 (−0.15; 0.10) 0.797 −0.04 (−0.17; 0.08) −0.12 (−0.25; 0.01) 0.218
HMWP First trimester 0.03 (−0.07; 0.12) −0.04 (−0.15; 0.06) 0.346 0.06 (−0.04; 0.15) −0.10 (−0.20; 0.01) 0.025#
Second trimester 0.05 (−0.05; 0.14) −0.04 (−0.14; 0.06) 0.234 0.05 (−0.05; 0.15) −0.10 (−0.20; −0.00)* 0.037#
Third trimester −0.04 (−0.13; 0.06) −0.14 (−0.24; −0.05)† 0.081# −0.03 (−0.14; 0.08) −0.21 (−0.30; −0.11)† 0.014#
DEHP First trimester 0.03 (−0.07; 0.12) −0.04 (−0.14; 0.07) 0.362 0.05 (−0.05; 0.15) −0.09 (−0.19; 0.02) 0.047#
Second trimester 0.04 (−0.05; 0.14) −0.05 (−0.14; 0.05) 0.218 0.06 (−0.04; 0.16) −0.09 (−0.19; 0.06) 0.034#
Third trimester −0.04 (−0.14; 0.06) −0.13 (−0.22; −0.03)† 0.136 −0.04 (−0.14; 0.07) −0.18 (−0.28; −0.09)† 0.033#
DNOP First trimester 0.02 (−0.07; 0.10) −0.04 (−0.14; 0.06) 0.390 0.02 (−0.07; 0.11) −0.07 (−0.17; 0.03) 0.204
Second trimester 0.04 (−0.05; 0.13) −0.06 (−0.16; 0.05) 0.219 −0.01 (−0.11; 0.09) −0.04 (−0.15; 0.07) 0.695
Third trimester 0.03 (−0.06; 0.13) −0.11 (−0.21; −0.01)* 0.038# −0.01 (−0.11; 0.09) −0.17 (−0.26; −0.07)† 0.047#
Values are regression coefficients (95% confidence interval) from linear regression models that reflect the difference in blood pressure in SDS for an interquartile
range increase in each natural log-transformed phthalate or bisphenol (in µmol/g creatinine) in boys or girls. Model includes child’s age and standardized height and
maternal age, education, parity, ethnicity, pre-pregnancy body mass index, alcohol consumption and smoking habits (specifically in early, mid and late pregnancy). $
Values are p-values from associations from linear regression models that reflect the significance of the interaction of gender and exposure on childhood blood
pressure.
DEHP, di-2-ethylhexylphthalate; DNOP, di-n-octylphthalate; HMWP, high molecular weight phthalates; LMWP, low molecular weight phthalate; PA, phthalic acid.
# p-value for interaction term<0.10.
* p-value < 0.05.
† Significant after correction for multiple testing (p-value threshold of 0.0098).
Table 4
Associations of maternal bisphenol urine concentration during pregnancy with childhood blood pressure at 10 years, stratified for boys and girls.
Measures of blood pressure at 10 years (in standard deviation scores, 95% confidence interval)
Mean systolic blood pressure Mean diastolic blood pressure
Exposure Trimester Boys Girls p-value$ Boys Girls p-value$
BP First trimester 0.04 (−0.07; 0.14) −0.05 (−0.16; 0.05) 0.266 0.08 (−0.04; 0.19) 0.01 (−0.10; 0.12) 0.382
Second trimester 0.13 (0.03; 0.23)† −0.08 (−0.18; 0.02) 0.004# 0.04 (−0.06; 0.15) −0.12 (−0.23; −0.02)* 0.038#
Third trimester 0.01 (−0.09; 0.11) 0.02 (−0.09; 0.13) 0.893 0.01 (−0.10; 0.12) −0.06 (−0.17; 0.05) 0.391
BPA First trimester 0.04 (−0.07; 0.15) −0.07 (−0.18; 0.03) 0.140 0.04 (−0.08; 0.16) 0.01 (−0.10; 0.11) 0.570
Second trimester 0.14 (0.04; 0.23)† −0.08 (−0.18; 0.02) 0.002# 0.05 (−0.05; 0.15) −0.12 (−0.22; −0.02)* 0.032#
Third trimester −0.01 (−0.10; 0.09) 0.05 (−0.05; 0.15) 0.369 0.02 (−0.08; 0.12) −0.02 (−0.12; 0.08) 0.552
BPS First trimester 0.06 (−0.05; 0.18) −0.02 (−0.14; 0.10) 0.373 0.11 (−0.02; 0.23) 0.03 (−0.09; 0.15) 0.441
Second trimester −0.05 (−0.15; 0.05) 0.04 (−0.06; 0.14) 0.173 −0.04 (−0.14; 0.07) 0.01 (−0.10; 0.11) 0.463
Third trimester NA NA NA NA NA NA
BPF First trimester 0.05 (−0.07; 0.16) −0.05 (−0.16; 0.07) 0.256 0.08 (−0.03; 0.20) −0.03 (−0.14; 0.11) 0.142
Second trimester NA NA NA NA NA NA
Third trimester 0.02 (−0.09; 0.12) −0.09 (−0.21; 0.02) 0.127 −0.05 (−0.16; 0.07) −0.12 (−0.23; 0.00) 0.584
Values are regression coefficients (95% confidence interval) from linear regression models that reflect the difference in blood pressure in SDS for an interquartile
range increase in each natural log-transformed bisphenol (in µmol/g creatinine) in boys or girls. Model includes child’s age and standardized height and maternal
age, education, parity, ethnicity, pre-pregnancy body mass index, alcohol consumption and smoking habits (specifically in early, mid and late pregnancy). $ Values
are p-values from associations from linear regression models that reflect the significance of the interaction of gender and exposure on childhood blood pressure.
BP, bisphenols; BPA, bisphenol A; BPF, bisphenol F; BPS, bisphenol S; NA: not applicable due to > 80% of concentrations below limit of detection.
# p-value for interaction term<0.10.
* p-value < 0.05.
† Significant after correction for multiple testing (p-value threshold of 0.0098).
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carboxypropyl)phthalate (mCPP) with lower blood pressure among
girls only (Supplemental Table S7). When performing a sensitivity
analysis concerning children born preterm or at low birth weight, effect
estimates of the associations of maternal phthalate urine concentrations
with blood pressure during childhood were comparable to the whole
group (Supplemental Table S8).
3.3. Maternal urine bisphenol concentrations and childhood blood pressure
Table 4 shows that among boys, after adjusting for confounders, an
IQR increase in the natural log transformed second trimester maternal
urine total bisphenol and BPA concentrations was associated with a
0.13 (95% CI 0.03; 0.23) SDS and 0.14 (95% CI 0.04; 0.23) SDS higher
childhood systolic blood pressure. These associations remained sig-
nificant after correction for multiple testing and also in the mutually
adjusted model (Supplemental Table S9). Among girls, higher second
trimester maternal urine total bisphenol and BPA concentrations tended
to be associated with a lower diastolic blood pressure (Table 4, basic
models given in Supplemental Table S10), although this association did
not remain after correction for multiple testing. In the mutually ad-
justed model, an IQR increase in the natural log-transformed urine total
bisphenol concentration during second trimester remained significantly
associated with a 0.14 (95% CI 0.24; 0.03) SDS lower diastolic blood
pressure among girls (Supplemental Table S9). When performing a
sensitivity analysis concerning children born preterm or at low birth
weight, effect estimates of the associations of maternal bisphenol urine
concentrations with blood pressure during childhood were comparable
to the whole group (Supplemental Table S11).
4. Discussion
4.1. Main findings
We observed in a population-based prospective cohort study that
the associations of exposure to phthalates and bisphenols during
pregnancy with blood pressure at 10 years old differ between boys and
girls. Higher fetal exposure to phthalates is associated with lower blood
pressure among girls, while higher fetal exposure to bisphenols is as-
sociated with higher blood pressure among boys at age 10 years.
4.2. Interpretation of main findings
Because of the wide-spread use of phthalates and bisphenols and
their ability to cross the placenta, exposure to these potential harmful
metabolites probably starts before birth. Exposure to phthalates and
bisphenols during fetal life may lead to vascular developmental adap-
tations, with subsequently an increase in the risk of hypertension and
cardiovascular disease in later life.
Few studies assessed the associations of fetal exposure to phthalates
with childhood blood pressure. (Vafeiadi et al., 2018; Valvi et al., 2015;
Warembourg et al., 2019) In a study among 350 Spanish mother–child
pairs, higher maternal urine total HMWP, total LMWP and mono-
ethylphthalate (mEP) concentrations were associated with lower sys-
tolic blood pressure among girls at 4 and 7 years old. (Valvi et al., 2015)
No association was observed for diastolic blood pressure among girls
and boys. In a Greek study among 230 mother–child pairs, higher
maternal urine mono-isobutylphthalate (mIBP) concentrations were
associated with lower diastolic blood pressure at 4–6 years old, espe-
cially among boys. (Vafeiadi et al., 2018) Higher maternal urine DEHP
concentrations tended to be associated with lower systolic and diastolic
blood pressure. Results from a multi-pollutant approach study among
1,277 children from different birth cohorts in Europe suggested that
maternal urine phthalate concentrations were not associated with
childhood blood pressure around 8 years of age (range 6.5–11 years).
(Warembourg et al., 2019) However, this study also reported that
higher childhood urine monobenzylphthalate (mBzBP) concentrations
were associated with lower systolic blood pressure during childhood.
(Warembourg et al., 2019) In the present study, higher fetal exposure to
(high molecular weight) phthalates was associated with lower blood
pressure at 10 years old among girls. Third trimester maternal mBzBP
was also associated with lower systolic and diastolic blood pressure
among girls, which is in line with the previous study. The lowering
effect on blood pressure by third trimester phthalates observed in our
study is in line with the few previous longitudinal studies in humans.
However, it is in contrast to our original hypothesis, which was mainly
based on animal studies and cross-sectional studies in humans. (Lu
et al., 2018) It is possible that these studies have been hindered by
residual confounding, based on the possibility of unhealthy life choices
leading to both increased phthalate exposure and cardiovascular risk.
The prospective association of fetal exposure to phthalates with lower
blood pressure in our study seems to be restricted to girls, which is in
line with the study from the INMA-Sabadell Birth Cohort Study, but not
with the results from the Rhea Study. The exposure to phthalates was
assessed during first trimester in the Rhea Study, while in the INMA-
Sabadell Birth Cohort Study the averages of first and third trimester
exposures were used, which is more in line with our study. Also, pre-
vious studies might have been underpowered to assess sex-specific ef-
fects, which might explain the different findings across studies. Alto-
gether, results from our and other prospective studies suggest that
higher fetal exposure to phthalates may be associated with lower blood
pressure among girls only.
Previous studies examining the associations of maternal bisphenol
concentrations with childhood blood pressure have only focused on
BPA. No association between maternal urine BPA concentrations and
childhood blood pressure was found in 235 Greek mothers and their 4-
year-old children. (Vafeiadi et al., 2016) In another study among 486
mother–child pairs, maternal mid-pregnancy urine BPA concentration
was positively associated with diastolic blood pressure at 4 years old
among boys and with systolic blood pressure at 4 years old among girls.
(Bae et al., 2017) In the most recent study including 1,277 children
around 8 years old from Europe, higher maternal urine BPA con-
centrations during pregnancy were also associated with higher diastolic
blood pressure. (Warembourg et al., 2019) In the present study, higher
fetal exposure to bisphenols was associated with higher blood pressure
at 10 years old among boys, but not among girls. The findings from this
study are not fully in line with previous studies in smaller samples with
4-year-old children, which might be due to different ages at which
blood pressure was measured. It is also possible that power issues may
have led to the absence of an association in the previous Greek study.
Thus, so far results from studies assessing the associations of fetal ex-
posure to bisphenol concentrations with blood pressure are not con-
sistent. However, findings from the largest study suggested an asso-
ciation of higher maternal urine BPA concentrations with an increase in
diastolic blood pressure during childhood, which is in line with our
findings.
Our results suggest that exposure to endocrine disruptors during
fetal life may have long-lasting effects on blood pressure during child-
hood. Due to the observational design of this study, we cannot draw
conclusions about causality. The observed effect estimates were small
but are of interest from a developmental perspective since blood pres-
sure tends to track into adulthood and even subclinical differences
during childhood are related to the development of cardiovascular
disease in later life. (Chen and Wang, 2008)
4.3. Possible underlying mechanisms
Numerous underlying mechanisms have been proposed for the hy-
pothesized adverse effects of exposure to phthalates and bisphenols on
blood pressure. It has been suggested that exposure to phthalates causes
an adverse inflammatory environment through oxidative stress.
(Ferguson et al., 2014) This hypothesis of an adverse inflammatory
environment is not in line with our results, which actually show a
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lowering effect of phthalates on blood pressure. It has previously been
shown that exposure to DEHP during fetal life lowered blood pressure
during adulthood among rats. (Martinez-Arguelles et al., 2013) The
suggested mechanism behind this is that DEHP causes reduced pro-
duction of aldosterone in the adrenal gland because of a decrease in
expression of the angiotensin II receptor, possibly by an epigenetic
mechanism. (Martinez-Arguelles et al., 2014; Martinez-Arguelles et al.,
2011) For BPA, it has been proposed that BPA damages kidney cells,
possibly via inducing oxidative stress. (Bosch-Panadero et al., 2018;
Nunez et al., 2018) The mechanisms for the sex-specific effects are not
completely known, but could involve sex-specific differences in PPAR-
activity of phthalates and the estrogenic effect of BPA. (Jalouli et al.,
2003; Huang and Chen, 2017; Mendelsohn and Karas, 2005)
4.4. Methodological considerations
An important strength of this study is the population-based cohort
design from fetal life onwards, with repeated measurements of multiple
maternal phthalate and bisphenol concentrations and measures of
childhood blood pressure in a large number of mother–child pairs.
Selection bias due to selective loss to follow-up would be of concern in
any study if the associations of prenatal phthalate and bisphenol con-
centrations with childhood blood pressure are different between par-
ticipants and non-participants. This seems unlikely, but cannot be ex-
cluded with certainty. Furthermore, we measured maternal urine
phthalate and bisphenol concentrations at one moment per trimester. It
is possible that one urine sample per trimester does not accurately re-
present the concentration during the whole trimester because of the
reported short biological half-lives of phthalates and bisphenols.
(Mattison et al., 2014; Braun et al., 2013) However, it has been found
that a single urine sample reflects phthalate exposure up to three
months. (Hauser et al., 2004) Variability has also been reported to be
biomarker specific, with strong correlations for LWMP metabolites and
reasonable correlations for BPA and DEHP metabolites. (Braun et al.,
2012; Mahalingaiah et al., 2008) In our study, we observed high
variability for bisphenols and moderate variability for phthalates across
pregnancy. We replaced the values of phthalate and bisphenol urine
concentrations below LOD by LOD divided by the square root of 2.
Single substitution is acceptable when the proportion of values below
the LOD is low but might introduce bias in the results as the proportion
of values below LOD increases. Overall, the detection rates of the
compounds are reasonable (< 35% below LOD), except for mono-
cyclohexyl-phthalate (mCHP) in the first trimester (79.5% of va-
lues < LOD), BPS in the second trimester (70.5% of values < LOD)
and BPF in the first and third trimester (59.6 respectively 71.5% va-
lues < LOD). We cannot disregard the possibility that, for these spe-
cific compounds, we did not have enough variability to detect asso-
ciations. Finally, we collected information on many potential
confounders. However, as in any observational study, residual con-
founding due to unmeasured lifestyle characteristics might remain an
issue. Unfortunately, we did not have information on phthalate or bi-
sphenol urine concentrations during childhood available in the full
group. This might be a limitation, since these concentrations might be
related to both the pregnancy concentrations and the outcomes of in-
terest. Previous studies reported associations of childhood phthalate or
bisphenol urine concentrations with their blood pressure. (Trasande
et al., 2013; Khalil et al., 2014) However, these studies might suffer
from reverse causality due to their cross-sectional design. Further stu-
dies are needed to take childhood concentrations into account.
5. Conclusions
In this population-based prospective cohort study, we found sex-
specific differences in the association of maternal urine phthalate and
bisphenol concentrations during pregnancy with childhood blood
pressure at 10 years old. Higher fetal exposure to (high molecular
weight) phthalates is associated with lower blood pressure among girls
and higher fetal exposure to bisphenols is associated with higher blood
pressure among boys. These results should be considered as hypothesis
generating and further studies are needed for replication and identifi-
cation of underlying mechanisms.
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